Application of a prebiotic in promoting the growth of Staphylococcus epidermidis CCSM0322
By screening and applying oligosaccharides such as fructooligosaccharides as prebiotics, the growth of Staphylococcus epidermidis CCSM0322 was promoted, and skin care products were prepared from the fermentation supernatant. This solved the shortcomings of existing technologies in promoting the growth of Staphylococcus epidermidis and skin health, and achieved significant antibacterial and antioxidant effects.
Patent Information
- Application Number
- CN202311653025.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-05
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2043-12-05
AI Technical Summary
Current technologies lack research on prebiotic screening for Staphylococcus epidermidis, making it impossible to effectively promote its growth and exert its skin health benefits.
Oligosaccharides such as fructooligosaccharides, galactooligosaccharides, isomaltooligosaccharides, and inulin were screened as prebiotics. The growth of Staphylococcus epidermidis CCSM0322 was promoted by fermentation medium. The fermentation supernatant was used to prepare skin care products to inhibit Staphylococcus aureus biofilm and reduce UVB-induced ROS.
It significantly promotes the growth of Staphylococcus epidermidis CCSM0322, produces more short-chain fatty acids, inhibits the formation of Staphylococcus aureus biofilm, and reduces UVB-induced ROS production in keratinocytes, exhibiting good antibacterial and antioxidant effects.
Smart Images

Figure CN117645968B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to application of prebiotics in promoting the growth of Staphylococcus epidermidis CCSM0322, and belongs to the technical field of microorganisms. Background Art
[0002] Staphylococcus epidermidis is a resident dominant bacterium on human skin and plays an important role in maintaining skin health. A large number of studies have shown that Staphylococcus epidermidis has multiple physiological functions (Stacy A, Belkaid Y. Microbial guardians of skin health [J]. Science, 2019, 363 (6424): 227-228.). Staphylococcus epidermidis metabolizes to produce antimicrobial peptides, short-chain fatty acids (SCFAs), etc. to fight infection, inhibit inflammatory factors and inhibit pathogenic bacteria. Lipoteichoic acid, a component of the cell wall of Staphylococcus epidermidis, can reduce inflammation caused by Propionibacterium acnes. 6-N-hydroxyaminopurine (6-HAP) produced by Staphylococcus epidermidis metabolism inhibits the activity of DNA polymerase and reduces the incidence of UVB-induced skin tumors in mice. Staphylococcus epidermidis can also promote wound healing. Studies have confirmed that Staphylococcus epidermidis has multiple functions, but not all Staphylococcus epidermidis have the above functions, and there are strain differences. Probiotics need to verify their probiotic functions at the strain level to clarify the efficacy of the strain. Screening for excellent strains is a time-consuming and laborious task. We are delighted to see more and more functional Staphylococcus epidermidis being discovered. At present, although true skin probiotics have not been scientifically defined and verified, a large number of studies have shown that Staphylococcus epidermidis is a potential probiotic on the skin, also known as the "Next Generation Probiotics" (NGP).
[0003] Prebiotics are a class of compounds that cannot be hydrolyzed by human digestive enzymes. After reaching the human intestine, they can be decomposed and utilized by intestinal flora, promote the proliferation of probiotics in the intestine, and produce beneficial metabolites. Currently recognized prebiotics include oligofructose (FOS), galacto-oligosaccharides (GOS), isomaltooligosaccharides (IMO), inulin, some polysaccharides and some dietary fibers. The concept of prebiotics comes from food nutrition science and is based on intestinal probiotics, such as lactobacillus and bifidobacterium, mainly carbohydrates. At present, there have been many reports that prebiotic ingredients such as trehalose, hyaluronic acid, β-glucan, GOS, FOS, inulin, etc. are added to cosmetic formulas, which have the effects of moisturizing, anti-aging, balancing skin microecology, and improving skin conditions. We see that the prebiotics recognized by the cosmetics industry are just borrowing the concept of intestinal prebiotics. At present, there is no in-depth study on the growth, metabolism and beneficial effects of skin on skin bacteria to verify whether they are prebiotics for skin bacteria.
[0004] The growth environment of skin bacteria is different from that of lactic acid bacteria. In the long-term coexistence with the host, they have formed special nutritional requirements and metabolic pathways. They can use the sebum secreted by the skin and the cells shed by the epidermis as "food" to synthesize the nutrients and metabolites they need. The prebiotic components of intestinal bacteria are probably not the best "food" for skin bacteria. Therefore, it is imperative to study the nutritional conditions suitable for skin bacteria, analyze their metabolites and the mechanisms by which they exert their effects and maintain skin health, and find prebiotics for skin bacteria.
[0005] The applicant has previously developed a strain of Staphylococcus epidermidis CCSM0322 (authorized patent number: ZH202210967956.3), which was deposited in the China Center for Type Culture Collection (CCTCC) on June 1, 2022, and its deposit number is CCTCC No.M 2022774. Experiments have confirmed that the CCSM0322 strain of Staphylococcus epidermidis is a potential skin probiotic with good anti-inflammatory and whitening effects. It can be seen that the CCSM0322 strain is a strain with development potential. The growth of strains is inseparable from nutritional needs, and different nutritional needs and culture conditions have obvious differences in the production of strain metabolites. Nutritional differences in strains cause different metabolites of strains, which in turn affects the efficacy on the skin. However, the prior art lacks research on prebiotic screening of Staphylococcus epidermidis. Summary of the invention
[0006] In response to the above problems, the present invention comprehensively investigated the effects of four common oligosaccharides (fructose, galacto-oligosaccharide, isomaltooligosaccharide and inulin) on Staphylococcus epidermidis CCSM0322 in terms of bacterial proliferation, fermentation supernatant pH, short-chain fatty acid production, inhibition of Staphylococcus aureus biofilm, and effects on UVB-induced ROS and inflammatory factors, screened prebiotics for Staphylococcus epidermidis CCSM0322, and laid a foundation for the future development of skin probiotics.
[0007] The present invention first provides an application of a prebiotic in promoting the growth of Staphylococcus epidermidis CCSM0322 and metabolizing to produce more short-chain fatty acids such as acetic acid and isovaleric acid, wherein the prebiotic is any one of oligosaccharides such as fructo-oligosaccharides, galacto-oligosaccharides, isomalto-oligosaccharides, inulin, etc. Preferably, the prebiotic is fructo-oligosaccharides. The concentration of the prebiotic is 0.1-3%.
[0008] The present invention also provides a use of a fermentation supernatant obtained by fermenting Staphylococcus epidermidis CCSM0322 in a culture medium containing prebiotics in the preparation of a skin care product that inhibits the formation of Staphylococcus aureus biofilm.
[0009] The present invention also provides a use of a fermentation supernatant obtained by fermenting Staphylococcus epidermidis CCSM0322 in a culture medium containing prebiotics in the preparation of a skin care product for reducing ROS of keratinocytes induced by UVB.
[0010] The present invention also provides an application of a fermentation supernatant obtained by fermenting Staphylococcus epidermidis CCSM0322 in a culture medium containing prebiotics in the preparation of an antioxidant and soothing skin care product.
[0011] The above-mentioned prebiotics are preferably fructo-oligosaccharides.
[0012] The preparation method of the above-mentioned fermentation supernatant is as follows: inoculate the CCSM0322 seed liquid into a sugar-free TSB medium containing 0.1-3% prebiotics (fructooligosaccharides, galacto-oligosaccharides, isomaltooligosaccharides and inulin) according to an inoculation rate of 2-3% by volume, culture on a shaker at 35-40°C for 8-20h, collect the supernatant by centrifugation, and obtain the fermentation supernatant of CCSM0322 fermented with each prebiotic.
[0013] The technical effect of the present invention is: the present invention provides a prebiotic that promotes the growth and application of Staphylococcus epidermidis, and the prebiotic is preferably oligofructose. Adding oligofructose significantly improves the bacterial growth of Staphylococcus epidermidis CCSM0322 and produces more short-chain fatty acids such as acetic acid and isovaleric acid. Adding oligofructose to obtain the TSB fermentation supernatant of the strain significantly inhibits the biofilm formation of Staphylococcus aureus and reduces the production of ROS in UVB-induced keratinocytes, has good antibacterial and antioxidant effects, and has broad application prospects in the preparation of antioxidant and soothing skin care products. The prebiotics screened and obtained by the present invention promote the growth of strain CCSM0322 and improve the probiotic properties of the strain. The present invention lays a foundation for the development of functional skin bacteria. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] Figure 1 This is a graph showing the effect of adding oligosaccharides at different concentrations on the growth of Staphylococcus epidermidis CCSM0322 in Example 1 of the present invention; wherein graphs A, B, C, and D are graphs showing the effect of adding oligofructose, oligogalactose, oligoisomaltosaccharide, and inulin at different concentrations, respectively;
[0015] Figure 2 is a growth curve diagram of Staphylococcus epidermidis CCSM0322 to which 2% of different oligosaccharides are added in Example 2 of the present invention;
[0016] Figure 3 This is a pH graph of the effect of adding 2% different oligosaccharides on the growth of Staphylococcus epidermidis CCSM0322 in Example 2 of the present invention;
[0017] Figure 4 This is a graph showing the effects of different oligosaccharides on the production of short-chain fatty acids acetic acid (a) and isovaleric acid (b) by Staphylococcus epidermidis CCSM0322 in Example 2 of the present invention;
[0018] Figure 5 is a graph showing adhesion of the fermentation supernatant of Staphylococcus aureus CCSM0322 fermented with different oligosaccharides to the biofilm of Staphylococcus aureus in Example 3 of the present invention;
[0019] Figure 6 This is a diagram showing the cytotoxicity experiment on primary keratinocytes of the fermentation supernatant of Staphylococcus epidermidis CCSM0322 fermented with different oligosaccharides in Example 4 of the present invention. DETAILED DESCRIPTION
[0020] In order to make the technical means, creative features, objectives and effects achieved by the present invention easier to understand, the present invention is described in detail below in conjunction with embodiments and drawings.
[0021] The materials and culture medium used in the following examples are as follows:
[0022] Fructooligosaccharide (Baoling Biotechnology Co., Ltd.), galacto-oligosaccharide (Baoling Biotechnology Co., Ltd.), isomaltooligosaccharide (Baoling Biotechnology Co., Ltd.) and inulin (purity>90%, Adamas Life Company).
[0023] Sugar-free TSB medium: 17.0 g / L tryptone; 3.0 g / L soy peptone; 2.5 g / L K2HPO4; 5.0 g / L sodium chloride; add different concentrations of fructooligosaccharides, galacto-oligosaccharides, isomaltooligosaccharides and inulin to prepare oligosaccharide culture medium of different concentrations, sterilize at 121°C for 15 min, and set aside.
[0024] TSB liquid culture medium: tryptone 17.0 g / L; soy peptone 3.0 g / L; sodium chloride 5.0 g / L; K2HPO4 2.5 g / L; glucose 2.5 g / L; sterilize at 121℃ for 15 min and set aside.
[0025] TSA culture medium: 15.0 g / L trypticase; 5.0 g / L soybean papain hydrolysate; 5.0 g / L sodium chloride; 15.0 g / L agar; sterilize at 121°C for 15 min and set aside.
[0026] Seed solution preparation method:
[0027] 1) Bacteria activation
[0028] Take out the streaked TSA solid plate of Staphylococcus epidermidis CCSM0322 stored at -80°C, place it in a 37°C constant temperature incubator for aerobic culture for 16-20 hours; activate it twice and set aside.
[0029] 2) Seed solution preparation
[0030] Inoculate Staphylococcus epidermidis CCSM0322 into TSB liquid culture medium and culture in a shaking incubator at 37°C for 16-20h. Measure the OD value of the fermentation broth. 600 , adjust to the appropriate concentration range, and adjust the OD 600 To 0.55-0.56, as seed liquid.
[0031] Example 1: Effects of different oligosaccharides on the growth of Staphylococcus epidermidis CCSM0322
[0032] Add oligofructose, galacto-oligosaccharide, isomaltooligosaccharide and inulin to sugar-free TSB medium to prepare oligosaccharide medium with a series of concentrations (0.018%, 0.036%, 0.072%, 0.15% and 0.3%), sterilize at 121℃ for 15min, and set aside. Inoculate CCSM0322 seed liquid into each fermentation tube according to the inoculum of 2.5%, shake and culture at 37℃ and 160r / min for 16-18h, and measure the OD of each fermentation liquid.600 The values were obtained by taking 6 parallels for each sample and calculating the average value. At the same time, blank control (sugar-free TSB medium), control 1 (sugar-free TSB medium + Staphylococcus epidermidis CCSM0322) and control 2 (sugar-free TSB medium + oligosaccharides) were set up. The growth of the strains under different concentrations of oligofructose, oligogalactose, oligomaltosaccharide and inulin were obtained. The results are as follows Figure 1 As shown, and calculate its EC 50 value.
[0033] EC 50 It is usually used to evaluate the activation or promotion effect of drugs on cells. 50 Lower values indicate better results. Figure 1 It can be seen that the addition of different concentrations of the four oligosaccharides can well promote the growth of Staphylococcus epidermidis CCSM0322. The EC values of oligofructose, galacto-oligosaccharide, isomaltooligosaccharide and inulin for promoting the growth of CCSM0322 were calculated. 50 The values were 0.1319%, 30.16%, 0.2008% and 0.1396% respectively. The effects of promoting the growth of strains were oligofructose>inulin>isomaltooligosaccharide>galacto-oligosaccharide, among which oligofructose had the best effect on Staphylococcus epidermidis CCSM0322.
[0034] Example 2: Effect of adding 2% oligosaccharides on the growth curve of Staphylococcus epidermidis CCSM0322
[0035] Fructooligosaccharides, galacto-oligosaccharides, isomaltooligosaccharides and inulin were added to sugar-free TSB medium to prepare 2% oligosaccharide medium, and 2% glucose was added as a control group, and sterilized at 121℃ for 15min. The seed liquid of CCSM0322 was inoculated into each fermentation tube according to the inoculation amount of 2.5%, and cultured in a shaking incubator at 37℃ and 160r / min. A total of 8 time points were selected, including 0, 4, 8, 12, 16, 20, 24 and 28h, and samples were taken every 4h. Samples were taken at each time point to measure the bacterial growth OD 600 , supernatant pH and short-chain fatty acid content.
[0036] The determination of short-chain fatty acids:
[0037] 1) Sample processing method: The fermentation broth was centrifuged at 10000 r / min for 15 min, and the supernatant was collected. 2 mL of the supernatant was added to a 10 mL centrifuge tube, and 0.4 mL of 50% H2SO4 and 2 mL of ether were added respectively, and mixed evenly. The mixture was shaken at 250 r / min for 45 min, and then centrifuged at 4°C and 10000 r / min for 5 min. The upper organic phase was collected and filtered with a 0.22 μm organic filter membrane before GC analysis, and stored at -20°C for future use;
[0038] 2) Gas chromatography conditions: Shimadzu GC instrument (GC-2010plus); chromatographic column: Agilent DB-WAX UI (60m×0.25μm×0.25mm); injection port and detector temperature set to 250℃; high-purity nitrogen was used as carrier gas (flow rate 12.1mL / min), and splitless detection mode was adopted; heating conditions: the sample volume was 1μL, and the temperature was increased from 75℃ to 180℃ at 10℃ / min and maintained for 1min, and then increased to 220℃ at 10℃ / min and maintained for 1min. Mixed standard was used: water-soluble fatty acid mixed standard solution (Northern Weiye Metrology Research Institute): glacial acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, a total of 6 components, each component was 1000μg / mL, and diluted with ultrapure water to a gradient of 5, 10, 20, 50, 100, 200, 500 and 800μg / mL.
[0039] The growth curve of strain CCSM0322 supplemented with 2% oligosaccharides is shown in Figure 2 ,from Figure 2 It can be seen that compared with the control group (sugar-free TSB medium), the addition of oligosaccharides significantly promoted bacterial growth, shortened the logarithmic growth period, increased the specific growth rate, and significantly increased the bacterial concentration. Compared with the four oligosaccharides, the growth-promoting effect was observed at the 16h time point of culture. Oligofructose>inulin>isomaltooligosaccharide>galacto-oligosaccharide. At the same time, the pH changes at each time point were observed. Figure 3 Compared with the control group (sugar-free TSB medium), the addition of oligosaccharides significantly promoted bacterial growth and acid production, and the pH of the fermentation liquid decreased. Among them, the trends of oligofructose, oligomaltose, oligogalactose and glucose were basically the same. With the increase of culture time, the pH of the fermentation liquid showed a downward trend. The time point when the pH value dropped sharply was 8-12h, and then the pH value changed slowly. Among them, the pH value of the fermentation liquid of inulin gradually increased after 12h of culture, showing a different trend.
[0040] We also monitored the changes in short-chain fatty acids at different time points. Figure 4 , and found that after adding oligosaccharides, two short-chain fatty acids, acetic acid and isovaleric acid, were mainly produced. Among them, the trends of fructooligosaccharides, isomaltooligosaccharides, galacto-oligosaccharides and glucose were basically the same. With the increase of culture time, the content of acetic acid and isovaleric acid increased significantly, and the content of acetic acid was greater than that of isovaleric acid. Among them, after 20 hours of culture, the content of acetic acid in inulin showed a downward trend, while the content of isovaleric acid gradually increased, showing different trends. At the same time, we calculated the total amount of acetic acid and isovaleric acid at each time point. Taking the 12h time point as an example, fructooligosaccharides>isomaltooligosaccharides>galacto-oligosaccharides>inulin.
[0041] from Figure 4It can be seen that the addition of oligosaccharides significantly promoted the production of two short-chain fatty acids, such as acetic acid and isovaleric acid, by Staphylococcus epidermidis CCSM0322 in TSB medium, which is different from the intestinal flora using oligosaccharides to mainly produce acetic acid, propionic acid and butyric acid. Previous studies have also confirmed that the types of short-chain fatty acids produced by adding different carbon sources or precursors are also different. For example, Staphylococcus epidermidis strain ATCC 12228 ferments glycerol to produce short-chain fatty acids such as acetic acid, butyric acid, and succinic acid, which further confirmed that butyric acid activates the short-chain fatty acid FFAR2 receptor to exert its anti-inflammatory effect (Keshari S, Balasubramaniam A, Myagmardoloonjin B, et al. Butyric acid from probiotic staphylococcus epidermidis in the skin microbiome down-regulates the ultraviolet-induced pro-inflammatory IL-6 cytokine via short-chain fatty acid receptor [J]. International journal of molecular sciences, 2019, 20 (18): 4477.).
[0042] Studies have shown that Staphylococcus epidermidis, as a symbiotic bacterium of healthy skin, metabolizes and produces short-chain fatty acids, which are beneficial for inhibiting the proliferation of pathogenic bacteria, reducing infection, and having anti-inflammatory effects. Adding various oligosaccharides promoted the growth of CCSM0322 bacteria and the production of short-chain fatty acids, among which oligofructose had the best effect.
[0043] Example 3: Effects of adding different oligosaccharide fermentation supernatants on Staphylococcus aureus biofilm
[0044] 1) Activation and cultivation of indicator bacteria
[0045] Staphylococcus aureus CCSM0424 (preservation number: CCTCC No.M 2022074) stored at -80℃ was streaked onto a TSA solid plate and placed in a 37℃ constant temperature incubator for aerobic culture for 16-20h; activated twice for standby use. Staphylococcus aureus CCSM0424 was inoculated into TSB liquid culture medium and cultured at 37℃ for 16-20h, and the OD of the fermentation broth was measured. 600 , adjust to the appropriate concentration range, and adjust the OD 600 To 0.55-0.56, as seed liquid.
[0046] 2) Preparation of different oligosaccharide fermentation supernatants
[0047] The CCSM0322 seed liquid was inoculated into the sugar-free TSB medium containing 2% oligosaccharides (fructooligosaccharides, galacto-oligosaccharides, isomaltooligosaccharides and inulin) at an inoculation rate of 2.5%, and the culture was shaken at 37°C and 160 r / min for 8 h. The supernatant was collected by centrifugation at 10,000 r / min for 15 min to obtain the fermentation supernatant of CCSM0322 fermented with different oligosaccharides.
[0048] 3) Semi-quantitative method of crystal violet for biofilm determination
[0049] Experimental groups: Group A (blank group): 200 μL blank TSB medium; Group B (control group): 50 μL bacterial suspension + 50 μL normal saline + 100 μL TSB medium; Group C (experimental group): 50 μL bacterial suspension + 50 μL fermentation supernatant of each strain at different culture time + 100 μL TSB medium.
[0050] The fermentation supernatant of each oligosaccharide was added to each well of a 96-well cell culture plate according to the grouping. Each group was set up with 4 replicate wells. The plates were placed in a 37°C constant temperature incubator and cultured for 4, 8, 12, 16, 20, 24, and 28 hours, respectively. The 96-well plates were then taken out and the remaining culture medium was aspirated. 200 μL of 0.9% saline was added to each well, and the 0.9% saline was aspirated to wash away the non-adherent bacteria. The plates were washed three times, and 0.01% crystal violet solution was added to the completely dried plates. The plates were stained for 15 minutes, washed twice with sterile deionized water to wash away the excess crystal violet solution, dried, and then 95% ethanol was used to release the fixed crystal violet solution. The OD was measured. 595 Absorbance value.
[0051] Staphylococcus aureus CCSM0424 is a strain isolated from the skin in the laboratory. Congo red test and crystal violet semi-quantitative staining confirmed that it has the ability to produce biofilms. Therefore, CCSM 0424 strain was used as the strain for studying biofilms. The adhesion curves of the fermentation supernatant of Staphylococcus epidermidis CCSM0322 fermented with oligosaccharides to the biofilm of Staphylococcus aureus were measured, as shown in the figure. Figure 5 As shown in the results, the addition of oligosaccharides to the fermentation supernatant of CCSM0322 can reduce the biofilm formation ability of Staphylococcus aureus. Among them, the fermentation supernatant of CCSM0322 obtained by adding oligofructose and glucose can significantly inhibit the production of biofilm of CCSM0424 strain, and it remains at a low biofilm production level throughout the growth process of Staphylococcus aureus. Compared with the control group, the amount of biofilm formation is significantly reduced. From the perspective of the inhibition of biofilm formation of Staphylococcus aureus by the four oligosaccharides, the inhibitory effect of adding oligofructose is significantly better than that of the other three oligosaccharides.
[0052] Example 4: Adding oligofructose fermentation supernatant to reduce UVB-induced ROS content in keratinocytes 1) Preparation of different Staphylococcus epidermidis CCSM0322 fermentation supernatants
[0053] The Staphylococcus epidermidis CCSM0322 strain was streaked on a TSA plate, cultured at 37°C for 16 to 20 hours, and activated twice. The CCSM0322 seed solution was inoculated into sugar-free TSB (labeled 287C), 2% oligofructose (labeled 287G) and 2% glucose (labeled 287P) sugar-free TSB medium at a 2.5% inoculation amount, and cultured on a shaking table at 37°C and 160 r / min for 16 hours. After the culture was completed, the supernatant was collected by centrifugation at 4°C and 10,000 r / min for 15 minutes to obtain the fermentation supernatant of CCSM0322 fermented with sugar-free TSB, oligofructose and glucose.
[0054] (2) Cell culture
[0055] Primary human keratinocytes (NEKs) were isolated from normal skin tissue and cultured in Promocell complete medium (Keratinocyte Growth Medium 2, C-20011) at 37°C and 5% CO2. When the cells grew to near confluence, they were digested with trypsin and passaged every 5 days.
[0056] (3) Cell viability assay
[0057] Take the NEKs cells in the best growth state, treat them routinely, and adjust the cell suspension density to 8×10 4 -1×10 5 / mL, 100μL cell suspension per well was inoculated in a 96-well plate and placed in a 37°C, 5% CO2 incubator for culture. 0.1%, 0.5%, 1%, 2.5%, 5% and 10% sugar-free TSB, 2% oligofructose and 2% glucose CCSM0322 fermentation supernatant were added and cultured for 24h, a control group was set up, and 3 parallel wells were set up for each experimental group. After 24h of culture, 10μL CCK-8 reagent (Japanese Tongren CK-04) was added to each well and incubated for 2h. The absorbance value was measured at 450nm using an ELISA reader, and the reference wavelength was 600nm or above.
[0058] (4) ROS detection
[0059] NEKs cells in the best growth state were taken and cultured at 2×10 4 The cell suspension was inoculated into a 96-well plate. NEKs cells were exposed to 312 nm wavelength and 10 mJ / cm 2UVB irradiation (Spectroline Model EB-160C UV lamp, USA). After UVB irradiation, the cells were washed with PBS, and then CCSM0322 fermentation supernatant containing 10% sugar-free TSB, 2% oligofructose and 2% glucose was added, and fresh culture medium was added and incubated for 24 hours. After 24 hours of culture, 5 μL ROS fluorescent colorimetric reagent (CellRox, Thermo) was added to each well, and the cells were washed with PBS after routine incubation for 1 hour. The fluorescence value was measured using an ELISA instrument, with an excitation wavelength of 485 nm and an emission wavelength of 520 nm.
[0060] The toxicity of CCSM0322 fermentation supernatant containing different concentrations of sugar-free TSB, 2% oligofructose and 2% glucose on primary keratinocytes was tested as follows: Figure 6 As shown in the figure, it can be seen that compared with the control group, the addition of CCSM0322 fermentation supernatant of sugar-free TSB (labeled 287C), 2% oligofructose (labeled 287G) and 2% glucose (labeled 287P) in the concentration range of 0.1%-10% did not show obvious cytotoxicity, among which sugar-free TSB (labeled 287C) and 2% oligofructose (labeled 287G) CCSM0322 fermentation supernatant can promote the growth of human primary skin keratinocytes. Here we selected 10% CCSM0322 fermentation supernatant for UVB-induced inflammation model experiment, and the experimental results are shown in Table 1.
[0061] Table 1 Effects of different fermentation supernatants on ROS in primary keratinocytes induced by UVB
[0062]
[0063] The experimental results show (Table 1) that there are differences in the effects of different added fermentation supernatants on the reactive oxygen species ROS produced by primary keratinocytes induced by UVB. After UVB irradiation (UVB group), the cells produced a large amount of reactive oxygen species. The addition of 10% oligofructose to the CCSM0322 fermentation supernatant had a scavenging rate of 10.5% for reactive oxygen free radicals ROS, showing the ability to scavenge free radicals. The sugar-free TSB group had a weaker protective effect against UVB-induced damage, while the glucose group also had a protective effect against its damage, but the effect was not as obvious as that of the oligofructose group. It can be seen that the addition of oligofructose promotes the metabolism of the CCSM0322 strain to produce beneficial substances, protecting primary keratinocytes from damage caused by reactive oxygen species caused by UVB.
[0064] In summary, the present invention provides a prebiotic for Staphylococcus epidermidis, which can significantly promote the growth of Staphylococcus epidermidis and improve the beneficial effect of the fermentation supernatant of the strain on promoting skin health. The prebiotic is preferably oligofructose, and the addition of oligofructose significantly improves the growth of Staphylococcus epidermidis CCSM0322 bacteria, and metabolizes to produce more short-chain fatty acids such as acetic acid and isovaleric acid. Adding oligofructose to obtain the TSB fermentation supernatant of the strain significantly inhibits the biofilm formation of Staphylococcus aureus, and reduces the generation of ROS in UVB-induced keratinocytes, with good antibacterial and antioxidant effects. The prebiotics obtained by screening the present invention have the advantages of promoting the growth of strain CCSM0322 and improving the probiotic properties of the strain. The present invention lays a foundation for the development of functional skin bacteria.
Claims
1. A use of a prebiotic in promoting the growth and metabolism of Staphylococcus epidermidis CCSM0322 to produce more acetic acid, wherein the prebiotic is oligofructose, and the concentration of the oligofructose is 0.1-3%.
2. An application of a fermentation supernatant obtained by fermenting Staphylococcus epidermidis CCSM0322 in a culture medium containing prebiotics in the preparation of a skin care product that inhibits the formation of Staphylococcus aureus biofilm and reduces ROS in UVB-induced keratinocytes; the prebiotics are oligofructose; the concentration of the oligofructose is 0.1-3%.
3. The use according to claim 2, characterized in that: The preparation method of the fermentation supernatant is as follows: inoculating the seed liquid of Staphylococcus epidermidis CCSM0322 into a sugar-free TSB medium containing 0.1-3% oligofructose at an inoculation rate of 2-3%, culturing on a shaker at 35-40° C. for 8-20 hours, and collecting the supernatant by centrifugation.
